Atlas Trials

Place of Circulating Biomarkers and Respiratory Eicosanoids in the Prognosis of Severe Forms of Covid-19 Pneumonia

Clinical trial NCT04485364 · COMPLETED

Trial details

NCT number
NCT04485364
Sponsor
Fondation Hôpital Saint-Joseph
Status
COMPLETED
Study type
OBSERVATIONAL
CoronavirusCovid19
Start date
2020-04-14
Primary completion
2022-05-31
Enrollment
97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.